The upregulated NAT10–FSP1 axis not only strengthens ferroptosis resistance and aggressive phenotypes (proliferation, migration, invasion) but also predicts poor prognosis in CRC [30]. The gene discussed is AIFM2; the disease is colorectal carcinoma.